Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

A new drug has been approved by Food Safety and Drug Administration (FDA) in September 2024 for schizophrenia ... Trospium chloride helps by blocking xanomeline from interacting with receptors ...

KarXT is thought ... by blocking the drug’s effects on the peripheral nervous system. In clinical trials, the drug has been shown to improve the proportion of hospitalised schizophrenia patients ...

Yes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...

Here are more doctors and nurses who are willing to share their shocking experiences, sourced from the BuzzFeed Community, and questions like "What's the craziest thing you have seen at a hospital?" ...

We strive to develop medications that do only 1 or 2 things (ie, blocking serotonin reuptake ... its share of discarded theories. We once thought that schizophrenia was exclusively a disease ...

The failure of institutions to stop research fraud has harmed development of Alzheimer's treatments and left an opening to ...

Schizophrenia is a serious mental disorder ... could be related to the levels of glutamate, a neurotransmitter thought to play a central role in the pathogenesis of the disease.

A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...